Immunomodulatory strategies for relapse after haploidentical hematopoietic stem cell transplantation in hematologic malignancy patients

Best Practice and Research: Clinical Haematology

Volumn 24, Issue 3, 2011, Pages 351-358

  Huang, Xiao Jun ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

hematological malignancies; prophylaxis; relapse; treatment; unmanipulated HLA mismatched haploidentical transplantation

Indexed keywords

ANTIGEN; HLA ANTIGEN; INTERLEUKIN 2; NONINHERITED MATERNAL ANTIGEN; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ARTICLE; CELL FUNCTION; DENDRITIC CELL; DISEASE FREE SURVIVAL; DONOR LYMPHOCYTE INFUSION; EVENT FREE SURVIVAL; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOMODULATION; IMMUNOSURVEILLANCE; INCIDENCE; MORTALITY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RELAPSE; T CELL DEPLETION; T LYMPHOCYTE;

EID: 80053041250     PISSN: 15216926     EISSN: 15321924     Source Type: Journal    
DOI: 10.1016/j.beha.2011.04.002     Document Type: Review

References (59)

1. W. Friedrich, S.F. Goldmann, and U. Vetter Immunoreconstitution in severe combined immunodeficiency after transplantation of HLA-haploidentical, T-cell-depleted bone marrow Lancet 1 1984 761 764 (Pubitemid 14173151)
2. F. Aversa, A. Terenzi, and A. Tabilio Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse J Clin Oncol 23 2005 3447 3454
3. X.J. Huang, D.H. Liu, and K.Y. Liu Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation Haematologica 92 2007 414 417
4. X.J. Huang, D.H. Liu, and K.Y. Liu Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies Bone Marrow Transplant 38 2006 291 297
5. X.J. Huang, Y. Wang, and D.H. Liu Administration of short-term immunosuppressive agents after DLI reduces the incidence of DLI-associated acute GVHD without influencing the GVL effect Bone Marrow Transplant 44 2009 309 316
6. Y. Kang, N.J. Chao, and F. Aversa Unmanipulated or CD34 selected haplotype mismatched transplants Curr Opin Hematol 15 2008 561 567
7. F. Aversa, A. Terenzi, and A. Carotti Improved outcome with T-cell-depleted bone marrow transplantation for acute leukemia J Clin Oncol 17 1999 1545 1550 (Pubitemid 29220863)
8. R.A. Brodsky, L. Luznik, and J. Bolanos-Meade Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases Bone Marrow Transplant 42 2008 523 527
9. L. Luznik, P.V. O'Donnell, and H.J. Symons HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide Biol Blood Marrow Transplant 14 2008 641 650 (Pubitemid 351664058)
10. H. Xiao-Jun, X. Lan-Ping, and L. Kai-Yan Partially matched related donor transplantation can achieve outcomes comparable with unrelated donor transplantation for patients with hematologic malignancies Clin Cancer Res 15 2009 4777 4783
11. D. Pende, S. Marcenaro, and M. Falco Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity Blood 113 2009 3119 3129
12. A. Dodero, C. Carniti, and A. Raganato Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies: posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery Blood 113 2009 4771 4779
13. H. Xiao-Jun, X. Lan-Ping, and L. Kai-Yan HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase Ann Med 40 2008 444 455
14. Y.J. Chang, X.Y. Zhao, and X.J. Huang Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies Biol Blood Marrow Transplant 14 2008 323 334
15. X.Y. Zhao, X.J. Huang, and K.Y. Liu Prognosis after unmanipulated HLA-haploidentical blood and marrow transplantation is correlated to the numbers of KIR ligands in recipients Eur J Haematol 78 2007 338 346
16. T. Ichinohe, T. Uchiyama, and C. Shimazaki Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomaternal microchimerism Blood 104 2004 3821 3828 (Pubitemid 39564463)
17. J.J. van Rood, F.R. Loberiza Jr., and M.J. Zhang Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling Blood 99 2002 1572 1577 (Pubitemid 34533028)
18. L.P. Xu, K.Y. Liu, and D.H. Liu The inferiority of G-PB to rhG-CSF-mobilized blood and marrow grafts as a stem cell source in patients with high-risk acute leukemia who underwent unmanipulated HLA-mismatched/ haploidentical transplantation: a comparative analysis Bone Marrow Transplant 45 2010 985 992
19. I.B. Villalobos, Y. Takahashi, and Y. Akatsuka Relapse of leukemia with loss of mismatched HLA resulting from uniparental disomy after haploidentical hematopoietic stem cell transplantation Blood 115 2010 3158 3161
20. L. Moretta, F. Locatelli, and D. Pende Natural killer alloeffector responses in haploidentical hemopoietic stem cell transplantation to treat high-risk leukemias Tissue Antigens 75 2010 103 109
21. T. Klingebiel, J. Cornish, and M. Labopin Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant group Blood 115 2010 3437 3446
22. F. Locatelli, D. Pende, and R. Maccario Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: how NK cells make the difference Clin Immunol 133 2009 171 178
23. F. Aversa, A. Tabilio, and A. Velardi Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype N Engl J Med 339 1998 1186 1193 (Pubitemid 28482127)
24. W.R. Drobyski, J. Klein, and N. Flomenberg Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alternative donor grafts Blood 99 2002 806 814 (Pubitemid 34525539)
25. W.A. Bethge, M. Haegele, and C. Faul Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: fast engraftment and low toxicity Exp Hematol 34 2006 1746 1752 (Pubitemid 44839013)
26. X.H. Luo, Y.J. Chang, and L.P. Xu The impact of graft composition on clinical outcomes in unmanipulated HLA-mismatched/haploidentical hematopoietic SCT Bone Marrow Transplant 43 2009 29 36
27. Y.J. Chang, X.Y. Zhao, and M.R. Huo Influence of lymphocyte recovery on outcome of haploidentical transplantation for hematologic malignancies Medicine (Baltimore) 88 2009 322 330
28. L. Ruggeri, M. Capanni, and E. Urbani Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants Science 295 2002 2097 2100 (Pubitemid 34229476)
29. L. Ruggeri, A. Mancusi, and M. Capanni Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value Blood 110 2007 433 440 (Pubitemid 47026866)
30. M. Stern, L. Ruggeri, and A. Mancusi Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor Blood 112 2008 2990 2995
31. A. Ferster, W. Bujan, and T. Mouraux Complete remission following donor leukocyte infusion in ALL relapsing after haploidentical bone marrow transplantation Bone Marrow Transplant 14 1994 331 332 (Pubitemid 24262562)
32. R. Or, E. Hadar, and M. Bitan Safety and efficacy of donor lymphocyte infusions following mismatched stem cell transplantation Biol Blood Marrow Transplant 12 2006 1295 1301 (Pubitemid 44858263)
33. P. Lewalle, A. Triffet, and A. Delforge Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study Bone Marrow Transplant 31 2003 39 44 (Pubitemid 36181820)
34. A. Ghosh, W. Koestner, and M. Hapke Donor T cells primed on leukemia lysate-pulsed recipient APCs mediate strong graft-versus-leukemia effects across MHC barriers in full chimeras Blood 113 2009 4440 4448
35. L. Vago, S.K. Perna, and M. Zanussi Loss of mismatched HLA in leukemia after stem-cell transplantation N Engl J Med 361 2009 478 488
36. J. Barrett, and B.R. Blazar Genetic trickery-escape of leukemia from immune attack N Engl J Med 361 2009 524 525
37. S. Slavin, S. Morecki, and M. Shapira Immunotherapy using rIL-2 activated mismatched donor lymphocytes positively selected for CD56+ for the treatment of resistant haematologic malignancies after stem cell transplantation Bone Marrow Transplant 33 2004 S174
38. C. Gentilini, U. Hilbers, and G. Hartung Early transfer of highly purified alloreactive CD56+CD3- NK-cells after haploidentical stem cell transplantation: promising results of a phase I study Bone Marrow Transplant 37 S1 2006 S35
39. U. Koehl, J. Sörensen, and R. Esser Immunotherapy with highly purified CD56+CD3- natural killer cells for paediatric patients after haploidentical stem cell transplantation Bone Marrow Transplant 37 S1 2006 S35
40. D.A. Rizzieri, R. Storms, and D.F. Chen Natural killer cell-enriched donor lymphocyte infusions from A 3-6/6 HLA matched family member following nonmyeloablative allogeneic stem cell transplantation Biol Blood Marrow Transplant 16 2010 1107 1114
41. S. Meyer-Monard, J. Passweg, and U. Siegler Clinical-grade purification of natural killer cells in haploidentical hematopoietic stem cell transplantation Transfusion 49 2009 362 371
42. S.R. Yoon, Y.S. Lee, and S.H. Yang Generation of donor natural killer cells from CD34(+) progenitor cells and subsequent infusion after HLA-mismatched allogeneic hematopoietic cell transplantation: a feasibility study Bone Marrow Transplant 45 2010 1038 1046
43. V. Decot, L. Voillard, and V. Latger-Cannard Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 expression Exp Hematol 38 2010 351 362
44. J.H. Fine, P. Chen, and A. Mesci Chemotherapy-induced genotoxic stress promotes sensitivity to natural killer cell cytotoxicity by enabling missing-self recognition Cancer Res 70 2010 7102 7113
45. A. Soriani, A. Zingoni, and C. Cerboni ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype Blood 113 2009 3503 3511
46. M.J. Szczepanski, M. Szajnik, and A. Welsh Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors Cancer Immunol Immunother 59 2010 73 79
47. J.E. Rubnitz, H. Inaba, and R.C. Ribeiro NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia J Clin Oncol 28 2010 955 959
48. U. Langenkamp, U. Siegler, and S. Jorger Human acute myeloid leukemia CD34+CD38- stem cells are susceptible to allorecognition and lysis by single KIR-expressing natural killer cells Haematologica 94 2009 1590 1594
49. J. Shi, G.J. Tricot, and T.K. Garg Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell-mediated lysis of myeloma Blood 111 2008 1309 1317 (Pubitemid 351213417)
50. S.H. Lim, S.A. Beers, and R.R. French Anti-CD20 monoclonal antibodies: historical and future perspectives Haematologica 95 2010 135 143
51. X.J. Huang, D.H. Liu, and K.Y. Liu Modified donor lymphocyte infusion after HLA-mismatched/haploidentical T cell-replete hematopoietic stem cell transplantation for prophylaxis of relapse of leukemia in patients with advanced leukemia J Clin Immunol 28 2008 276 283
52. T. Ichinohe, E. Maruya, and H. Saji Long-term feto-maternal microchimerism: nature's hidden clue for alternative donor hematopoietic cell transplantation? Int J Hematol 76 2002 229 237 (Pubitemid 43020311)
53. X.J. Huang, X.Y. Zhao, and D.H. Liu Deleterious effects of KIR ligand incompatibility on clinical outcomes in haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion Leukemia 21 2007 848 851
54. X.Y. Zhao, X.J. Huang, and K.Y. Liu Reconstitution of natural killer cell receptor repertoires after unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation: analyses of CD94: NKG2A and killer immunoglobulin-like receptor expression and their associations with clinical outcome Biol Blood Marrow Transplant 13 2007 734 744
55. W.J. Norde, I.M. Overes, and F. Maas Myeloid leukemic progenitor cells can be specifically targeted by minor histocompatibility antigen LRH-1-reactive cytotoxic T cells Blood 113 2009 2312 2323
56. J.R. Passweg, A. Tichelli, and S. Meyer-Monard Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation Leukemia 18 2004 1835 1838 (Pubitemid 39530014)
57. M.D. Ianni, F. Falzetti, and A. Carotti Adoptive immunotherapy with tregs prevents GvHD and favours immune reconstitution after HLA haploidentical transplants for hematological malignancies Blood (ASH Annu Meet Abstracts) 114 2009 abstract 4
58. E. Nadal, A. Fowler, and E. Kanfer Adjuvant interleukin-2 therapy for patients refractory to donor lymphocyte infusions Exp Hematol 32 2004 218 223 (Pubitemid 38177648)
59. K.Y. Liu, Y.H. Chen, and D.H. Liu A pilot study of low-dose recombinant interleukin-2 for acute lymphoblastic malignancy after unmanipulated allogeneic blood and marrow transplantation Bone Marrow Transplant 42 2008 535 539